PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Aurisco – 04/02/2025
Biopharma Group – 19th March 2025

Clinical Trial Supply New England Conference 2019: PCI’s Jeremy Osborne to Share his Expertise on Accelerating into Early Clinical Trials with Speed and Flexibility

Philadelphia, USA – March 14, 2019. Leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) will share its specialist clinical trials expertise at the upcoming Clinical Trial Supply New England Conference 2019 (The Westin Boston Waterfront, Boston, MA, March 26-27).

PCI’s Jeremy Osborne, Manager of Project Management, will take to the stage on Tuesday, March 26 at 9am EST, with his presentation ‘Accelerating into Early Clinical Trials with Speed and Flexibility’. Jeremy will discuss how to create solutions to optimize limited drug supplies for clinical trials and the advantages of using Just-in-Time packaging for early phase studies. In addition, he will discuss how to utilize phase-specific processes to accelerate through Phase I and II, along with how to develop strategic choices to maximize flexibility in clinical supply strategies.

Jeremy boasts a successful career in guiding customers through their clinical supply management strategies and leads a team of project management specialists at PCI. He said: “Ensuring that projects are managed efficiently, cost-effectively and on time are crucial to the services customers expect and what we strive to deliver at PCI. We have a number of effective and reliable strategies in place to meet this demand and I am delighted to be able to share our wealth of knowledge with the New England region.”

PCI recently hosted events highlighting the advantages of executing early phase clinical studies.  With considerable economic advantages paired with a favorable regulatory environment, broad access to diverse patient populations and well-established infrastructure, pharmaceutical and biotech companies are discovering many advantages to executing studies in the region, including speed to early phase studies.

PCI is a trusted partner for the global healthcare industry and has been providing development solutions that increase client’s products’ speed to market and opportunities for commercial success. PCI has proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Many clients view PCI as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives.

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40
Eppendorf – 18.03.2025